Abstract
Aging-related organ degeneration is driven by multiple factors including the cell maintenance mechanisms of autophagy, the cytoprotective protein αKlotho, and the lesser known effects of excess phosphate (Pi), or phosphotoxicity. To examine the interplay between Pi, autophagy, and αKlotho, we used the BK/BK mouse (homozygous for mutant Becn1F121A) with increased autophagic flux, and αKlotho-hypomorphic mouse (kl/kl) with impaired urinary Pi excretion, low autophagy, and premature organ dysfunction. BK/BK mice live longer than WT littermates, and have heightened phosphaturia from downregulation of two key NaPi cotransporters in the kidney. The multi-organ failure in kl/kl mice was rescued in the double mutant BK/BK;kl/kl mice exhibiting lower plasma Pi, improved weight gain, restored plasma and renal αKlotho levels, decreased pathology of multiple organs, and improved fertility compared to kl/kl mice. The beneficial effects of heightened autophagy from Becn1F121A was abolished by chronic high Pi diet which also shortened life-span in the BK/BK;kl/kl mice. Pi promoted beclin 1 binding to its negative regulator BCL2, which impairs autophagy flux. Pi downregulated αKlotho, which also independently impairs autophagy. In conclusion, Pi, αKlotho, and autophagy interact intricately to affect each other. Both autophagy and αKlotho antagonizes phosphotoxicity. In concert, this tripartite system jointly determines longevity and lifespan.
Keywords: Aging, autophagy, BCL2, beclin 1, fertility, αKlotho, longevity, NaPi cotransporter, phosphorus, phosphotoxicity
One Sentence Summary
Becn1 role in phosphate, αKlotho and lifespan
INTRODUCTION
Aging is an inevitable multi-organ deterioration initiated and accelerated by genetic, epigenetic, and environmental factors; among which is the lesser known factor of inorganic phosphate (Pi) intake in excess of the need of the organism (1–3). Excessive Pi intake is highly prevalent in the developed world (4). The ill effects of excess Pi at the cellular, organ, and whole organism levels are collectively termed “phosphotoxicity” (5–7). Compelling observational studies showed that phosphotoxicity is associated with reduced longevity in several species (8). In humans, high plasma Pi is an independent risk factor for cardiovascular disease (CVD) and mortality in patients with chronic kidney disease (CKD) and also in the general population (9). However, these associations albeit compelling, cannot prove casuality. In addition, the molecular mechanisms mediating phosphotoxicity in accelerating aging, and in initating and excerbating CVD are complex and multifactorial, and not understood (5, 10–12). Animal experiments showed that high Pi accelerates aging, and reduction of plasma Pi by either restriction of dietary Pi or induction of urinary Pi leak via genetic manipulation prolongs lifespan (10).
Autophagy is a universally conserved process employed by eukaryotic cells to degrade and reutilize the constituents of cytoplasm and organelles (13). Low autophagy is associated with shortened lifespan, and high autophagy prolongs life (14–16). Whether the detrimental effect of Pi on accelerating aging is related to autophagic flux has not been explored. We recently generated a mouse strain with a global knock-in of a F121A single amino acid substitution in the BH3 domain of mouse beclin 1 (Becn1F121A), which impairs the ability of the negative regulator BCL2 to bind to beclin 1, consequently leaving beclin 1 to increase autophagic flux in multiple organs including brain, kidney, and muscle without alteration of endogenous levels of beclin 1 or/and BCL2 expression (15, 17). Mice harboring mutant Becn1F121A have reduced cerebral amyloid accumulation, less cognitive decline, and increased survival when afflicted with Alzheimer’s-like disease (17), and less premature aging in mice with hypomorphic αKlotho allele (kl/kl) (15, 18) compared to Alzheimer mice and kl/kl mice respectively.
αKlotho was originally identified functionally as an aging suppressor due to the multi-organ premature degeneration in the homozygous hypomorph kl/kl mice (18) and a “longevity” phenotype in transgenic αKlotho overexpressing mice (Tg-Kl mice) (19). Transmembrane αKlotho is a co-receptor for fibroblast growth factor (FGF)23 (20–24), which is a Pi-regulating hormone promoting negative Pi balance (25). The ectodomain of membrane-anchored αKlotho is shed by secretases (26–28) into the circulation, and exerts FGF23-independent actions including anti-aging, anti-apoptosis, anti-senescence, and blockade of vascular calcification (29, 30). Soluble αKlotho, a cleaved extracellular domain of membrane-anchored αKlotho protein was proposed to also function as a deliverable soluble receptor for FGF23 in very high concentrations in vitro (31). The cellular and molecular mechanisms by which αKlotho deficiency initiates and/or promotes aging are not understood. Over-activity of insulin/insulin-like growth factor (32), plasminogen activator inhibitor-1 (33), low ectonucleotide pyrophosphatase/phosphodiesterase 1 (34), and high Pi (35) have all been proposed to be pathobiologic intermediates mediating the deleterious effects of αKlotho deficiency. The model to be tested is shown in Fig. 1A where defective autophagy, αKlotho deficiency, and phosphotoxicity all directly accelerate aging; in addition, each of these three factors also could modulate or amplify each other, thus secondarily contribute to aging. In this study, we used genetic and pharmaceutic approaches to manipulate autophagy activity, αKlotho levels, and dietary Pi content to examine the inter-relationships of these three factors and how they converge to acceleate aging (Fig. 1A).
MATERIALS AND METHODS
Mice and murine strains
All animal work was conducted strictly following the Guide for the Care and Use of Laboratory Animals by the National Institutes of Health and was approved by the Institutional Animal Care and Use Committee at the University of Texas Southwestern Medical Center. Wild type (WT) 129 S1/SVlmJ (129sv) mice were purchased from Jackson laboratory (Bar Harbor, ME, USA). WT mice were housed in a temperature-controlled room (22.0±0.2 °C) with a 12:12 hour light-dark cycle and were given ad libitum access to tap water and allowed free access to standard rodent chow (Teklad 2016, Harlan, Madison, WI) unless stated otherwise. Equal male and female animals were used. Usually 10–12 week-old mice were used unless specifically indicated. Mouse lines were cross-mated with WT 129sv mice for more than 10 generations and genotyped with standard PCR protocols described in the previous publications: heterozygous αKlotho hypomorphic (kl/+) mouse (36), transgenic mouse with αKlotho overexpression (Tg-kl) (36), GFP-LC3 reporter (LC3) mouse (36), homozygous Becn1F121A knock-in (BK) mouse (17), heterozygous global Becn1 knockout (Becn1+/−) mouse (37), homozygous BCL2AAA knock-in (Bcl2AAA) mouse (38). BK/WT;kl/+ mouse line was generated by cross-mating BK mice with kl/+ mice and BK/BK;kl/kl mouse line was generated when BK/WT;kl/+ mice were cross-mated with themselves.
Cell culture and cell lines
Two types of cell lines were used. (1) Opossum kidney PTH responsive cells (OKP cells), a proximal tubule–like epithelial cell line, were grown on culture dishes or on insert filters with 0.4 μm pores (Transwell Inserts, Corning Incorporated). Cells grown on culture dishes were collected for immunoblot and culture media for lactic acid dehydrogenase (LDH) assay to evaluate cell injury. Cells grown on insert filters were fixed for immunocytochemistry or transmission electron microscopy. (2) Human embryonic kidney cells (HEK-293) lacking a native Na-dependent Pi cotransporter type II a (NaPi-2a) and NaPi-2c protein expression, were transiently transfected with human NaPi-2a and NaPi-2c plasmids with Lipofectamine 2000 (Invitrogen, Carlsbad, CA) for characterization of newly generated NaPi-2a and 2c antibodies.
High phosphate diet
High Pi rodent chow (2.0% w:w) was purchased from Harlan company (Teklad 08020, Harlan, Madison, WI) and used to examine the effect of high Pi diet on autophagic flux and αKlotho expression.
Recombinant αKlotho protein supplementation
Recombinant αKlotho protein containing the ectodomain of mouse αKlotho (amino acid number 31–982) with C-terminal V5 and 6xHis tags was generated in our laboratory as described (39, 40). For the in vivo experiments, recombinant αKlotho protein (0.3 mg/kg body weight) or vehicle (normal saline) was given for 4 weeks via ALZET® 1004 osmotic minipumps (DURECT Corporation, Cupertino, CA).
In vivo administration of autophagy modulators
To modulate autophagy activity in mice, rapamycin (LC Laboratories, Woburn MA) and chloroquine (Sigma-Aldrich, St. Louis, MO) were prepared as previously reported (15, 36, 41), and were intraperitoneally given for 4 weeks via ALZET® 1004 osmotic minipumps (DURECT Corporation, Cupertino, CA) at doses of: rapamycin 28 mg/Kg, and chloroquine 50 mg/Kg respectively.
Blood, urine, and kidney samples collection
At predetermined times, 24-hour urine was collected in individual metabolic cage. The mice were anesthetized with isoflurane and blood samples were collected in heparinized tubes, centrifuged at 3,000 × g for 5 min at 4°C, and plasma was separated and stored at −80°C until analysis. At termination, mice were sacrificed under anesthesia, and the kidneys were isolated and sliced. One slice was fixed with 4% paraformaldehyde and embedded in a paraffin block for histological and immunohistological studies; the remaining renal tissue was snap-frozen in liquid N2 and stored at −80°C until RNA or protein extraction.
Plasma and urine chemistry was analyzed using a Vitros Chemistry Analyzer (Ortho-Clinical Diagnosis, Rochester, NY). Plasma and urine creatinine concentrations were measured using a P/ACE MDQ Capillary Electrophoresis System and photodiode detector (Beckman-Coulter, Fullerton, CA) at 214 nm (36, 39).
In vivo and in vitro administration of Tat-beclin 1 peptides
Tat-beclin 1 11 peptides (TB-11) (YGRKKRRQRRR-GG-VWNATFHIWHD) and Tat-Scrambled peptides (TB-Sc) (YGRKKRRQRRR-GG-WNHADHTFVWI) were synthesized by the University of Texas Southwestern Protein Technology Center as reported previously (42, 43). To examine the effect of beclin 1 on modulation of Pi metabolism in mice, we intraperitoneally injected TB-11 or TB-Sc to LC3 mice (2 mg/kg daily for 4 weeks), followed by intraperitoneal chloroquine injection (50 mg/kg) 4 hours prior to sacrifice. Twenty-four-hour urine was collected, blood drawn, and Kidney tissues harvested.
To examine the protective effect of beclin 1 on phosphotoxicity in cultured cells, TB-11 or TB-Sc (10 μM for 24 hours), OKP cells were incubated with normal (0.96 mM) or high (3.0 mM) Pi culture media. Culture media were collected for LDH determination and cells harvested for the evaluation of autophagy activity.
Measurement of plasma αKlotho
Soluble αKlotho was determined by immunoprecipitation-immunoblot as described (12, 44, 45). Intact parathyroid hormone (PTH) was quantified by ELISA (Alpco, Salem, NH); 1,25-(OH)2D by EIA using (Immunodiagnostic Systems, Scottsdale, AZ); and C-terminal FGF23 by ELISA (Immutopics, San Clemente, CA) following manufactures’ instructions.
Plasmids
The GFP-LC3 plasmid was kindly provided by Dr. Mizushima N (Tokyo Medical and Dental University, Tokyo, Japan). Its information was described in our previous publications (36, 41). Full length human NaPi-2a and NaPi-2c were subcloned and inserted with Xhol and SaclI restriction enzymes into eGFP-N3 vector (Clontech, Palo Alto, California). All sequences were confirmed by the sequencing Core at UT Southwestern Medical Center.
Fluorescent microscopy and transmission electron mcroscopy
For the study of high Pi effect on autophagic flux with fluorescent microscopy, OKP cells were seeded on insert filters or on culture dishes, and transiently transfected with GFP-LC3 plasmid as described previously (15, 36, 41). One day after transfection, cells were treated with culture media containing 0.96, 2.0 or 3.0 mM Pi for 24 hours respectively.
OKP cells were seeded, grown on 0.4 μm pores Snapwell™ Insert filters (Corning Incorporated Life Sciences, Tewksbury, MA), and fixed with 2.5% glutaraldehyde at 4°C for 2 hours. The filters (with cells) were cut to 1×1 mm pieces, embedded in 3% agarose, post-fixed in 1% osmium tetroxide, and embedded in Resin812. Ultrathin sections were cut by using a Microtome Leica Ultracut R (Leica Microsystems Inc, Buffalo Grove, IL, USA). The sections were stained with 1% uranyl acetate and Reynold’s lead citrate. The sections were examined and photographed by using a Jeol 1200 EX transmission electron microscope (Jeol Ltd., Akishima, Japan) as described (36, 46). Twenty cells in each slide were observed and autophagosomes and multilamellar bodies (MLBs) were counted based on typical morphologic features by one independent investigator blinded to study protocol.
Antibodies
The following antibodies were used for immunoblotting and/or immunohistochemistry: mouse monoclonal anti-beclin 1 (Santa Cruz Biotechnology, Santa Cruz, CA), mouse monoclonal anti-BCL2 (Santa Cruz Biotechnology, Santa Cruz, CA), rat monoclonal anti-Klotho antibody (KM2076) (TransGenics, Kobe, Japan), rabbit polyclonal anti-LC3 antibody (Novus Biologicals, Littleton, CO), mouse monoclonal antibody against α-SMA (Sigma Aldrich, St. Louis, MO), mouse monoclonal anti-p62/SQSTM1 antibody (Abnova, Taiwan), mouse monoclonal antibody against β-actin (Sigma Aldrich, St. Louis, MO), and mouse monoclonal antibody against glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Sigma Aldrich, St. Louis, MO). Rabbit polyclonal antibodies against human NaPi-2a or NaPi-2c were made by Yenzym Antibodies, LLC (San Francisco, CA). The peptide sequences for immunizing rabbit for NaPi-2a and NaPi-2c are human NaPi-2a peptide (77–96, CKLALEEEQKPESRLVPKLRQ) or human NaPi2c peptide (579–599, KATTKEAYCYENPEILASQQL) respectively and the specificity of anti-serum was confirmed with kidney tissues from NaPi-2a or 2c knockout mice. Secondary Abs coupled to horseradish peroxidase for immunoblotting, or to FITC, Alexa Fluor, or Cy5, and Syto 61 red fluorescent nuclear acid for immunohistochemistry were purchased from Molecular Probes/Invitrogen (Molecular Probes Inc., Eugene, OR).
Kidney histology and histopathology
Kidney tissues were fixed in 4% paraformaldehyde for 16 hours at 4 °C, and 4 μm sections of paraffin embedded kidney tissues were stained with Hematoxylin and Eosin (H&E) and Trichrome (TC). To evaluate renal fibrosis, TC stained kidney sections were examined and photographed by two investigators blinded to the experimental protocol. The fibrotic area and fibrosis intensity were quantified with Image J program with established methods (40, 41, 47).
Immunohistochemistry and immunoblotting
Four μm sections of paraffin-embedded kidney were subjected to immunohistochemistry following established protocols (36, 40, 41, 47). Total kidney lysate covering all kidney zones were prepared and subjected to SDS-PAGE as described (40, 47).
Assessment of cardiac fibrosis and hypertrophy
Paraffin-embedded heart sections were stained with Trichrome to assess fibrosis. Images were then scanned with Zeiss laser confocal scanning microscope (Carl Zeiss Micro-Imaging, Inc. Thornwood, NY), and analyzed using the Image J program (12, 40, 48). The scar ratio is the area of collagen deposition divided by the total area of cardiac musculature. To measure surface area of cardiomyocytes in the hearts, heart sections were labeled with wheat germ agglutinin (WGA) conjugated to Alexa Fluor 555 (ThermoFisher Scientific, Eugene, OR). Image J software (NIH) was used to quantify cross-sectional cell surface area along the mid-chamber free wall of left ventricle based on WGA-positive staining (12, 40, 48).
Von Kossa staining and calcium content measurement
The aorta was stained for calcification with Von Kossa (45). Tissue sections were incubated with 1% silver nitrate solution under ultraviolet light for 30 minutes followed by incubation with 5% sodium thiosulfate for 10 minutes to remove the un-reacted silver. Aortic sections were counterstained with nuclear fast red, photographed blindly by two investigators using Axioplan 2 Imaging (Carl Zeiss MicroImaging, Inc. Thornwood, NY). The calcium concentration in tissues was measured using the o-cresolphthalein complexone method (Sigma-Aldrich, St. Louis, MO) (45, 49). The calcium content (μg/mg protein) was quantified by normalization to protein concentration determined by Bradford protein assay.
Quantitative polymerase chain reaction (qPCR)
For PCR, total RNA was extracted by RNAeasy kit (Qiagen, Germantown, MD) from mouse kidneys. Complimentary DNA (cDNA) was generated with oligo-dT primers using SuperScript III First Strand Synthesis System (Invitrogen, Carlsbad, CA) according to manufacturer’s protocol. Primers of mouse αKlotho and cyclophilin used for qPCR and conditions were shown in our previous publications (40, 45). Data are expressed at amplification number of 2−ΔΔCt by normalization of cyclophilin and comparison to controls.
Statistical analysis
Survival rates during the survival study was assessed using the log rank test to compare the differences in Kaplan-Meier survival curves. Data are expressed as means ± S.D. unless otherwise specified. Analysis was performed with Sigma Plot 13.0 software (Systat Software, Inc. San Jose, CA). As appropriate, statistical analysis was performed using unpaired Student-t-test, or one-way or two-way analysis of variance (ANOVA) followed by Student-Newman-Keuls post hoc test when applicable as specified. A value of P ≤ 0.05 was considered statistically significant.
RESULTS
The tripartite interacting model we tested is shown in Fig. 1A, depicting how each of the three factors can individually and directly influence aging but also interact, modulate, and amplify each other. These relationships will be tested individually and in concert with in vivo and in vitro models.
Autophagy and phosphate: high autophagy activity is associated with low plasma Pi and high phosphaturia
The first arm of Fig. 1A we tested was the influence of autophagy on Pi homeostasis. Before full embarkment of experiments, we first ensured that we can fully explore “phosphate sensitivity” of mouse strains to enable testing of phosphotoxicity. We crossed the BK/BK mouse (homozygous for the mutant Becn1F121A) onto a 129sv background of the kl/kl mice. The rationale is based on our personal experience and knowledge of the relative resilience of the C57BL6 mice to phosphotoxicity. The new line of BK/BK mice had a mixed C57BL/6;129sv background, but maintained the same features of high autophagic flux (Supplementary Fig. 1A–C) demonstrated by higher ratios of LC3II/I, as previously reported for the BK/BK mice in C57BL/6 background (15, 17).
To study the role of autophagy in Pi homeostasis, we measured Pi in BK/BK mice and found that they had lower plasma Pi compared to WT litermates (Fig. 1B left panel) and higher urinary fractional excretion of Pi (FEPi), indicating heightened renal excretion accounting for the lower plasma Pi (Fig. 1B right panel). Pi is regulated by the kidney in a filtration-reabsorption mode, and Pi reabsorpiton is mediated by type II Na+-dependent Pi cotransporters (NaPi) including NaPi-2a and 2c in the renal proximal tubules, and phosphaturia is usually achieved by downregulation of Pi reabsoption by NaPi-2a and −2c (6, 24, 50). Due to the variable and nondependable quality of commerical antibodies, we generated and validated new rabbit polyclonal antibodies against NaPi-2a and NaPi-2c ourselves for this project (Supplementary Fig. 2) and used these two new antibodies to measure the expression of NaPi-2a and NaPi-2c in BK/BK mice. We found that BK/BK mice had lower NaPi-2a and 2c protein expression in the kidney (Fig. 1C) and in apical membrane of renal proximal tubules of BK/BK mice (Fig. 1D and Supplementary Fig. 3), indicating that increased autophagy downregulates NaPi’s expression in renal tubules to decrease Pi reabsorption and promote phosphaturia.
Autophagy and Klotho effects on phosphate: level of autophagy activity is positively correlated with αKlotho levels, and both autophagy and αKlotho modulate plasma Pi
We next explored the more complex tripartite relationship between plasma Pi, autophagy activity, and αKlotho levels. Since plasma Pi is inversely associated with lifespan (8), we measured plasma Pi in several mouse lines manipulated to have low, normal or high autophagy acitivity and also low, normal, or high αKlotho, which is a known phosphaturic substance (24). Both the BK/BK and Tg-Kl mice with high autophagy and αKlotho respectively, had higher FEPi and lower plasma Pi compared to WT (Fig. 1E). Reduced autophagy was achieved by two methods. We used the haploinsufficient Becn1+/− mice with reduced Beclin 1 and autophagic flux (37, 51), and the Bcl2AAA mice with knock-in of mutant BCL2 at three phosphorylation residues in the non-structured loop region, T69A, S70A and S84A (homologous to human S87A) which confers constitutive BCL2 inhibition of Beclin 1 (38). Regardless of how autophagy flux was decreased, both Becn1+/− and Bcl2AAA mice had higher plasma Pi and lower FEPi compared to WT mice (Fig. 1E). At one extreme end is the kl/kl mouse, which has the highest plasma Pi and lowest FEPi (Fig. 1E). The important finding is that in contrast to the severe hyperphosphatemia in kl/kl mice, plasma Pi was remarkably reduced in the 10-week-old double BK/BK;kl/kl mice which surprisingly approaches that of WT mice of the same age indicating rescue of the severe kl/kl phosphste-retaining phenotype by activation of autophagy flux (Fig. 1E).
To further examine the relationship between beclin 1 activity, plasma Pi and αKlotho status, we measured autophagic flux and αKlotho levels in the kidney and compared them with those in kl/kl mice (extremely low αKlotho) (18) and a transgenic mouse line with global overexpression of αKlotho by a universal promoter (Tg-Kl mice) resulting in modestly elevated αKlotho (1.5x wild type) and lower plasma Pi (24, 32). Two mouse lines with low beclin 1 activity (Becn1+/− and Bcl2AAA) had higher plasma and renal aKlotho levels compared to mouse line with high beclin 1 activity (BK/BK) (Fig. 1F, G). Thus, Beclin 1 activity is negatively correlated with plasma Pi levels and positively associated with FEPi levels (Fig. 1E), and plasma and renal αKlotho levels (Fig. 1F, G).
Autophagy and Klotho: high beclin 1 activity restores αKlotho in αKlotho hypomorphic mice
The next arm of the tripartite model to be tested is whether autophagy is upstream of and modulates αKlotho. Plasma Pi is a downstream surrogate for systemic αKlotho bioactivity. To fully define the time profile of changes in plasma Pi, we longitudinally followed plasma Pi in mice with all 4 genotypes (kl/kl, kl/kl;BK/BK, WT, BK/BK) from weaning to 120 weeks of life. In parallel with the dramatic elongation of lifespan of the kl/kl mice by increasing beclin 1 activity (Fig. 2A), BK/BK;kl/kl mice sustainably gained body weight (Fig. 2B) even though they were still smaller than WT littemates at same age, and had decreased levels of plasma Pi (Fig. 2C), which had never been observed in kl/kl mice. Interestingly, BK/BK;kl/kl mice had increased autophagy flux in the kidney compared to kl/kl mice although the flux was lower than that of BK/BK mice at age of 6 or 10 weeks (Fig. 2D), indicating that one can increase autophagy activty in the kl/kl mice by elevation of beclin 1 activity.
To study the change in plasma αKlotho in BK/BK;kl/kl mice, we longitudinally followed plasma αKlotho in all of 4 genotypes from weaning to 10 weeks after birth. Not suprisingly, with a dysfunctional αKlotho promoter (the primary lesion in kl/kl mice), plasma and renal αKlotho levels remained undetectable at 6 weeks in the BK/BK;kl/kl mice (Fig. 2E, F). However, note that αKlotho protein was actually weakly detectable in the kidney and plasma, and higher than that of kl/kl mice by 8 weeks of age (Supplementary Fig. 4). Surprisingly by 10 weeks, αKlotho protein levels were unequivocally appreciable in both plasma and the kidney (Fig. 2E, F) albeit still lower than WT mice. Notably, αKlotho levels in the kidney of BK/+;kl/kl mice bearing only one copy of the activated becn1 mutant, were lower than those in BK/BK;kl/kl mice at 12 weeks old (Supplementary Fig. 5), suggesting that beclin 1-induced restoration of αKlotho is of dose-dependence either directly or via better maintenance of Pi homoestasis.
End organ phenotype: high beclin 1 activity alleviates cardiac pathology in αKlotho hypomorphic mice
If the individual components of the tripartitie model (Fig. 1A) interact with each other to affect health maintenance, there should be detectable end organ effects as we manipulate each of the components. We demonstrated that high autophagy rescues αKlotho deficiency and positions Pi homeostasis away from phosphotoxicity. Here we examined the effect of high beclin 1 activity on the cardiovascular system, because cardiomyopathy and vascular calcification are two cardinal manifestions and prinicpal contributors to the short lifespan in kl/kl mice (52, 53), and in humans with CKD who classically have low αKlotho and high serum Pi levels (12, 54). BK/BK;kl/kl mice had basically normal histology of the cardiovascular system at 10 weeks of age (Fig. 3A – D). Vascular calcification in aortic roots, and cardiac hypertrophy and fibrosis normally present in the kl/kl mice were significantly attenuated in BK/BK;kl/kl mice compared to kl/kl mice (Fig. 3A – D), indicating that high beclin 1 activity ameliorates cardiovascular abnormalities prominently present in kl/kl mice.
End organ phenotype: high beclin 1 activity restores reproductive function in both male and female αKlotho hypomorphic mice
Restoration of αKlotho level, abrogation of phosphotoxicity, and improvement of cardiovascular outcome are pivotal results of heightened autophagy. Another important end organ effect of the trinity of modulators is reproductive health. Infertility and early loss of reproduction are characteristics of the kl/kl mice and so are features of aging (18, 55). Both male and female kl/kl mice stopped growing after weaning with small body mass (Supplementary Fig. 6A). Male kl/kl mice had testicular atrophy with less spermatids and no spermatocytes release into the lumen of seminiferous tubules. Female kl/kl mice had uterine atrophy and ovarian atrophy (Supplementary Fig. 6B, C). There was either complete absence or much reduced follicles and interstitial infiltration in female kl/kl mice. Interestingly, both male and female BK/BK;kl/kl mice had near normal body size and normal morphogy (Supplementary Fig. 6B) and histology (Supplementary Fig. 6C) of testis and ovary respectively compared to male and female WT mice, and also had intact reproduction (data not shown) suggesting that infertility in kl/kl mice was rescued by high beclin 1 activity. Moreover, both male and female BK/+;kl/kl mice were fertile after cross-mating (data not shown), indictating that beclin 1F121A exerts a dominant effect, and one copy of Becn1F121A is able to protect the murine reproductive system from αKlotho deficiency and phosphotoxicity.
End organ phenotype: high beclin 1 activity alleviates renal abnormalities in the αKlotho hypomorphic mice
In addition to the heart and reproductive organs, another important end organ phenotype in αKlotho deficiency is the heightened propensity for kidney disease. Trichrome-stained kidney sections were used to examine the effect of high autophagy activity on renal histology. The renal fibrosis characteristically seen in kl/kl mice was remarkably decreased in BK/BK;kl/kl mice (Supplementary Fig. 7 and Fig. 3E). The fibrotic marker α-SMA in the kidney was reduced in BK/BK;kl/kl mice (Fig. 3F) compared to kl/kl mice. Ectopic calcification which is prominently present in the kidney of kl/kl mice was not even detectable in BK/BK;kl/kl mice (Fig. 3G).
Early pharmacologic modulation of autophagy activity influences murine growth
To confirm that the high beclin 1 activity-associated prevention of premature death and organ and tissue degeneration is directly attributable to upregulation of autophagy flux, we used an alternative mode of pharmacologic activation of autophagy to treat kl/kl mice with rapamycin, a known autophagy inducer, for 4 weeks (Fig. 4A). The rapamycin-treated kl/kl mice had slightly higher body weight gain, which was similar to, but less than αKlotho-treated kl/kl mice. In contrast, chloroquine (CQ), an autophagy suppressor, exaggerated the slow growth (Fig. 4B). Moreover, rapamycin-treated kl/kl mice had lower levels of plasma Pi, which were similar to those in αKlotho-treated kl/kl mice, while CQ-treated mice had higher levels of plasma Pi than vehicle-treated kl/kl mice (Fig. 4C). Although a short period of rapamycin treatment did not increase renal αKlotho protein expression (Fig. 4D), renal fibrosis was significantly attenuated in kl/kl mice treated with either rapamycin or αKlotho, but worsened in CQ-treated kl/kl mice (Fig. 4E). Therefore, the high autophagy-induced improvement of renal abnormalities in kl/kl mice may result at least in part from improved Pi homeostasis prior to changes in αKlotho levels.
Phosphate effect on autophagy: high Pi diet reverses high beclin 1 activity-induced improvement of growth
If improved Pi homeostasis in BK/BK mice is mediating the phenotypic rescue in kl/kl mice, one should be able to overwhelm the beneficial effect with Pi loading. We therefore fed mice with the 3 genotypes (WT, BK/BK, and BK/BK;kl/kl) with high Pi diet starting at 6-weeks old for a duration of 6 weeks. From our experience, kl/kl mice are very fragile, intolerant to high Pi, and will universally succumb, so they were not studied. High Pi diet decreased mouse growth, which was more appreciable in BK/BK;kl/kl mice than the WT and BK/BK mice (Fig. 5A and B), indicating that the beneficial restoration of growth by high autophagy was abolished by high Pi diet. The 12-week survival of BK/BK;kl/kl mice was 92% under normal Pi diet, which was reduced to 52% after 6-weeks of high Pi feeding (Fig. 5C). The low survival rate was associated with higher plasma Pi (Fig. 5D), low autophagy flux in the kidney (Fig. 5E), and low endogenous αKlotho (Fig. 5F). The reduction in mortality in BK/BK;kl/kl mice previously observed was dramatically reversed by high Pi diet. Note that BK/BK mice were more resistant to phosphotoxicity under the high Pi diet than WT mice because BK/BK mice maintained relatively normal plasma Pi (Fig. 5D), higher autophagy flux in the kidney (Fig. 5E), and higher αKlotho expression in the kidney (Fig. 5F).
High Pi diet blunts the high beclin 1 activity-induced improvement of renal and cardiac phenotypes in αKlotho hypomorphic mice
In addition to poor growth (Fig. 5A to C), higher plasma Pi levels (Fig. 5D), lower autophagic flux (Fig. 5E), and lower αKlotho (Fig. 5F) in the kidney after 6-week high Pi dietary intake, were associated with higher α-SMA expression in the kidney (Fig. 6A) and more renal fibrosis (Fig. 6B) in BK/BK;kl/kl mice compared to WT or BK/BK mice, suggesting that BK/BK;kl/kl mice are more sensitive to phosphotoxicity.
Six weeks of high dietary Pi challenge also induced cardiac fibrosis (Fig. 6C) and hypertrophy (Fig. 6B), and upregulated markers of hypertrophy (α-actinin) and fibrosis (α-SMA) in WT mice (Fig. 6E), which were similar to our previous findings (12, 40). Interestingly, BK/BK mice were more resistant, and the BK/BK;kl/kl mice were more susceptible to cardiac phosphotoxicity.
We examined the effect of high Pi diet on parameters of mineral metabolism in BK/BK;kl/kl mice and compared these changes in BK/BK;kl/kl mice with other genotypes. In addition to decreasing plasma and renal αKlotho (Fig. 5F and Table 1), 6-week of high Pi diet increased plasma FGF23, and slightly elevated plasma 1,25-(OH)2-vitamin D (1,25-(OH)2-D) in both WT, and BK/BK;kl/kl mice but not in BK/BK mice. Clearly there were more severe changes in low αKlotho, high plasma FGF23 and 1,25-(OH)2-D induced by high Pi diet in BK/BK;kl/kl mice compared to WT and BK/BK mice.
Table 1.
αKlotho (pmol/l) | cFGF23 (RU/ml) | 1,25-(OH)2D (pg/ml) | ||
---|---|---|---|---|
Normal Pi diet | ||||
WT | 45.6±3.5 (14) |
105.7±28.2 (12) |
104.5±13.4 (14) |
|
BK/BK | 48.7±4.1 (14) |
139.5±26.4 (12) |
96.5±4.6 (12) |
|
BK/BK;kl/kl | 41.2±3.5 (12) |
144.5±32.3 (14) |
113.4±12.5 (14) |
|
P value | >0.05 | >0.05 | >0.05 | |
High Pi diet | ||||
WT | 31.1±2.3 (14) |
347.4±35.0 (14) |
277.2±31.6 (16) |
|
BK/BK | 42.2±3.3**
(16) |
353.6±45.6 (12) |
124.2±21.4**
(14) |
|
BK/BK;kl/kl | 30.2±3.0##
(10) |
431.7±84.3*#
(10) |
347.4±42.1**##
(10) |
|
P value | <0.01 | <0.05 | <0.01 |
Three mouse lines (WT, BK/BK, and BK/BK;kl/kl) were fed with normal Pi (0.7%) or high Pi (2.0%) diet for 6 weeks starting at 6 weeks old. The ratio of female and male mice were 50:50. After 6 weeks of dietary Pi challenge, mice were terminated and plasma was harvested for the measurement of soluble αKlotho, C-terminal FGF23, and 1,25-(OH)2D. Data are presented as means ± S.D., the number in parentheses is sample size. The statistical analysis was conducted with one-way ANOVA followed by post hoc tests for any two groups.
P<0.05
P<0.01 vs WT mice
P<0.05
P<0.01 vs BK/BK mice by one-way ANOVA followed by Student-Newman-Keuls post hoc test. cFGF23: c-terminal fragments of fibroblast growth factor-23; kl/kl: homozygous αKlotho hypomorphs; Pi: inorganic phosphate; 1,25-(OH)2D: 1,25-dihydroxyl-vitamin D; WT: wild type.
High Pi downregulates autophagy flux and αKlotho
To complete the study of all the arms in the trinity in Fig. 1A, we explored if high Pi diet modifies autophagic flux in kidneys. Mice with normal kidney function consuming high Pi diet for 2 weeks did not have significantly higher plasma Pi (Fig. 7A left panel) likely due to the appropriate compensatory urinary Pi excretion (Fig. 7A right panel). But despite the lack of detectable hyperphosphatemia, Pi load per se led to lower autophagic flux (Fig. 7B, C) and lower renal αKlotho protein and mRNA (Fig. 7B, and Supplementary Fig. 9). In addition, high Pi-fed mice had increased beclin 1/BCL2 complex (Fig. 7D). Taken together, high Pi diet not only markedly downregulated αKlotho, but also decreased autophagic flux in the kidney, suggesting that all of these three factors may interplay in a highly regulated network.
It is difficult to draw definitive conclusions within the complexity of the whole organism due to the multiple possible intermediate mediators. To address the direct effect of high Pi on autophagic flux, we proceeded to OKP cells, a renal epithelial cell line (36). High Pi media significantly reduced autophagy flux (Fig. 7E, F) and induced cell injury demonstrated by higher levels of LDH in the media, which was Pi concentration-dependent (Supplementary Fig. 7). Both LC3-I and LC3-II proteins were increased as well as elevation of p62 and diminution of LC3 punctas (Fig. 7E, F), which suggest incomplete block of autophagic flux when cells are exposed to high Pi. Moreover, high Pi stabilized the beclin 1/BCL2 complex in cells (Fig. 7G). Electron photomicrographs showed significantly fewer autophagosomes and autolysosomes, but massive accumulation of MLBs delimited by a single layer of plasma membrane (56) in cells treated with high Pi media compared to normal Pi treated cells. Notably, we cannot find a single MLB in cells treated with normal Pi media despite extensive searching (Fig. 7H). Accumulation of MLBs in the tissues is generally attributable to insufficient degradation of deposited MLBs (57, 58). It is conceivable that high Pi downregulates autophagy flux probably through two mechanisms: insufficient biogenesis of autophagosomes due to stabilizing beclin 1/BCL2 complex, and incapacity of autolysosomes processing and recycling.
Beclin 1 peptides upregulates autophagy flux and protects against phosphotoxicity
Tat-beclin 1 11 (TB-11) is an autophagy-inducing peptide comprising 11 amino acids derived from beclin 1 diglycine linked to the HIV Tat protein. These peptides are in the retro-inverso D-configuration (42, 43). TB-11 is a shorter peptide with higher penetrance into cells than, but has similar bioactivity as Tat-beclin 1 (18 amino acids), (42, 43, 59). Beclin 1 peptide is an active functional unit of beclin 1 protein (42, 43, 59). To test beclin 1 effect on prevention against phosphotoxicity, we first determined TB-11 effect on Pi metabolism in vivo and found that 4-week TB-11 significantly reduced plasma Pi probably through induction of urinary Pi leak (Fig. 8A). To further confirm TB-11 effect on autophagy activity in vivo, we explored the profile of autophagy flux in the kidneys after TB-11. TB-11 upregulated αKlotho expression increased the ratio of LC3II/I and LC3II and reduced p62 in the kidney (Fig. 8B) as well as elevation of LC3 punctas in renal tubules (Fig. 8C).
We next used the OKP cell line as in vitro model to test direct protective action of TB-11 against phosphotoxicity. After co-incubation of OKP cells with TB-11 and high Pi (3.0 mM) for 24 hours, we found higher autophagic flux as demonstrated by higher LC3 II/I, LC3 II and lower p62 expression compared to TB-Sc (Fig. 8D). Importantly, LDH release induced by high Pi was significantly reduced compared to TB-Sc (Fig. 8E), supporting cytoprotection by TB-11 against phosphotoxicity.
DISCUSSION
This is the first demonstration of an interactive relationship of autophagy (beclin 1), αKlotho, and Pi, and how the three can act individually or via modulating each other in controlling health and longevity (Fig. 1A). We propose that high Pi, low αKlotho, and low autophagy are independent contributors to multi-organ degeneration with reciprocal mutual amplifications. High Pi downregulates autophagic flux via increased beclin 1/BCL2 complex formation, and suppression of αKlotho. Either high or low αKlotho further exacerbate low autophagic flux, constituting a triple interactive and self-amplifying loop. Low Pi, increased autophagy, and αKlotho, function independently and cross-regulate each other to synergistically retard aging and prolong lifespan. Disruption of one or all three can have undesirable consequence on aging and health (Fig. 1A). A few salient features of the current dataset deserve discussion.
Autophagy affects phosphate homeostasis through induction of phosphaturia
The role of autophagy in prevention of aging in the kidney and the heart has been documented (15, 36), but the underlying mechanisms have not been deciphered. Normal Pi homeostasis contributes to maintenance of lifespan and retardation of degeneration in multiple organs including the heart and kidney (10, 12, 60). Genetic and dietary normalization of blood Pi rescues many phenotypes including ectopic calcification in the kidney, heart and aorta, cardiac abnormalities, early death, infertility in aging animals (8, 10, 61). The current study provides in vivo evidence that high beclin 1 activity induces phosphaturia via downregulation of renal NaPi-2a and 2c expression, and the negative Pi balance consequently upregulates αKlotho, retards aging, and ameliorates tisues and organs degeneration to better maintain function of the cardiovascular, reproductive and renal systems.
The conclusion was fortified by finding of similar results with pharmcologic manipulation of autophagy in vivo. Even a short period of rapamycin treatment made kl/kl mice gain weight, lowered their plasma Pi, but without detectable change in αKlotho, while CQ treatment had the opposite effect on kl/kl mice. The reduction of plasma Pi by rapamycin or other mTOR inducers has been reported in humans (62) and animals (63, 64) but the effect on NaPi2a expression has been less consistent (65). In addition, whether the rapamycin-induced phosphaturia is autophagy-dependent or/both autophagy-independent is unknown. The current dataset proves that rapamycin could induce phosphaturia and prevent phosphotoxicity via upregulation of autophagy flux as one of its mechanisms, which is supported by the animal experiment in the BK mice and TB-11-treated WT mice. The contribution of non-autophagy-dependent effects of rapamycin remains plausible and deserves future exploration.
Improvement of Pi metabolism might be a sufficient driving force to enhance autophagy and longevity. The decreased plasma Pi and increased urinary Pi excretion in mice after adminstration of TB-11, the active and functional peptide of beclin 1 futher proves the concept that high autophagy in the kidney promotes negative Pi balance. The restored body growth and reduced mortality in BK/BK;kl/kl mice was abolished by high Pi diet further supporting the phosphotoxic effect on accelerating aging. The in vitro experiment with TB-11 showing lower LDH release from proximal tubule cells cultured in high ambient Pi provides direct evidence that beclin 1 is cytoprotective against phosphatoxicity.
The role of autophagy in regulation of renal transport (66, 67) including water (68, 69), glucose (70), cysteine (71) and other electrolytes (72) have been reported. The current manuscript provides new data linking autophagy with phosphate transport in the renal tubules. Autophagy might modulate NaPi2a/2c endocytosis via the canonical mechanisms of modification of trafficking (73–76) to control renal tubular Pi reabsorption. Alternatively, there can be novel mechanisms by which autophagy can regulated NaPi protein distribution and activity.
αKlotho modulates phosphate metabolism and autophagy activity
Despite the fact that αKlotho is phosphaturic, high Pi paradoxically but reproducibly induces αKlotho deficiency in mice (12, 40); with interesting disparity in normal humans (77). In addition, αKlotho deficiency decreases autophagic flux in vivo and in vitro (36). All of the above effects are associated with aging. The deleterious effect of high Pi and the beneficial effect of low Pi on aging and survival can be αKlotho-dependent or αKlotho-independent (10). Aging and high plasma Pi in kl/kl mice are ameliorated by restoration of αKlotho with viral delivery of αKlotho gene (78), transgenic overexpression αKlotho (32), or intraperitoneal administration of soluble αKlotho protein (79). Regardless of the congenital or acquired origin, the curent and previous published data (15, 36) suggest that αKlotho deficiency may be instrumental in lowering autophagic flux either directly or indirectly by causing phosphotoxicity. Reduction of plasma Pi effectively and sufficiently prolongs lifespan and rescues aging in αKlotho null mice (10, 35) strongly proving the concept that abnormal Pi metabolism is a trigger or/and accelerator to aging progression.
High phosphate suppresses autophagy flux
The effect of high Pi diet on autophagic flux is not universally consistent (80–83); probably dependent upon different target cells, levels of Pi, length of exposure, and other concomitant stressors. We examined autophagy markers in the kidney of mice treated with a short-period (2 weeks) of high Pi diet and confirmed lower autophagic flux without inducing hyperphosphatemia. Our cell culture experiments in OKP cells, a renal epithelial cell line (36, 84) offered direct and unequivocal evidence that high ambient Pi reduces autophagy flux; both LC3-I and LC3-II proteins were increased as well as elevation of p62, suggesting blockade of autophagic flux. Electron photomicrographs showed significantly fewer autophagosomes and autolysosomes, but massive accumulation of MLBs delimited by single plasma membrane (56) in cells treated with high Pi media. The accumulated MLBs have been proposed to be related to deficiency of fusion of autophagosomes with lysosomes or/and lysosomal disorders (57, 58), which eventually disturbs autophagy flux (58, 85–87). It appears that there are potentially more than one mechanisms through which, high Pi reduces autophagy flux. High Pi decreases autophagosome formation through promoting beclin 1/BCL2 complex, and impairs autophagosome-lysosome function consequently blocking autophagosome and autolysosome recycling. However, high Pi-induced low autophagy in mice is likely a combined outcome of both direct Pi effects and indirect effects from αKlotho donwregulation.
Limitations
(1) Because no αKlotho knockout line was used in this study; we are not able to investigate whether beclin 1 prolongs mouse lifespan completely independently of αKlotho. Based on the time course of plasma Pi and αKlotho during BK/BK;kl/kl mice development, and the rapamycin effect on kl/kl mice, we proposed that beclin 1-induced phosphaturia decreases plasma Pi, consequently restoring αKlotho and rescuing prematuring age phenotypes. The beneficial effects of plasma Pi reduction after rapamycin administration (63), or through knockout of NaPi-2a on αKlotho knockout mice support direct Pi toxic effect on accelerating aging (10) that is αKlotho-independent. (2) Due to limited blood sample volumes, we did not measure PTH, another important mineral hormone participating in Pi homeostasis. So we could not exclude PTH’s role in our in vivo models. (3) The current proof-of-conceptual study provides evidence to support that high Pi stabilizes and αKlotho disrupts beclin 1/BCL2 complex respectively. However, the mechanism(s) of modulation of the complex formation remain to be studied in the future. (4) High Pi-induced MLBs accumulation in cells is interesting but how high Pi induces aberrant contents degradation in autolysosomes needs to be explored.
In conclusion
Phosphate, autophagy, and αKlotho function as a closely interwoven tripartite network in health maintenance. Beclin 1 suppresses renal NaPi-2a/2c expression, increases phosphaturia, and reduces plasma Pi. Low plasma Pi upregulates αKlotho which further combats aging. High plasma Pi suppresses while αKlotho stimulates autophagy. Autophagy and αKlotho interactively counteract phosphotoxicity, prolong lifespan and attenuate aging-associated multiple organ degeneration (Fig. 1A).
Supplementary Material
ACKNOWLEDGMENTS
The authors would like to thank Dr. Noboru Mizushima (Tokyo Medical and Dental University, Tokyo, Japan) for providing the transgenic GFP-LC3 reporter mice and eGFP-LC3 plasmid. The authors are grateful to the expertise of Dr. Peng Li, Ms. Nancy Gillings and Mr. Jianning Zhang in the experiments and Dr. Vishal Patel for critical reading of this manuscript. This work was supported by NIH grants R01-CA109618 (B.L.), R01-DK091392 and R01-DK092461 (B.L., O.W.M., and M.C.H.), UT Southwestern Medical Center O’Brien Kidney Research Center (P30-DK07938) (O.W.M.), U19AI199725 (B.L.), a Fondation Leducq grant 15CBD04 (B.L., S.S., A.F.F.), the Simmons Family Foundation grant (O.W.M.), the Pak Center Innovative Research Support, Endowed Professors Collaborative Research Support, and the Pak-Seldin Center for Metabolic Research (O.W.M. and M.C.H.).
ABBREVIATIONS
- ANOVA
analysis of variance
- BCL2AAA
BCL2AAA knock-in
- Becn1+/−
heterozygous global Becn1 knockout
- BK
Becn1F121A knock-in
- CVD
cardiovascular disease
- CKD
chronic kidney disease
- CQ
chloroquine
- cDNA
complimentary DNA
- ELISA
enzyme-linked immunosorbent assay
- FGF23
fibroblast growth factor-23
- GAPDH
glyceraldehyde-3-phosphate dehydrogenase
- H&E
Hematoxylin and Eosin
- kl/+
heterozygous αKlotho hypomorphic
- LDH
lactic acid dehydrogenase
- LTL
Lotus Tetragonolobus lectin
- MLB
multi-lamellar body
- NaPi-2a
Na-dependent Pi cotransporter type II a
- NaPi-2c
Na-dependent Pi cotransporter type II c
- OKP
opossum kidney cell PTH responsive
- Pi
inorganic phosphate
- PTH
parathyroid hormone
- Tg-kl
transgenic αKlotho overexpression
- qPCR
quantitative polymerase chain reaction
- SD
standard deviation
- TC
trichrome
- WGA
wheat germ agglutinin
- WT
wild type
REFERENCES
- 1.AlGhatrif M, Wang M, Fedorova OV, Bagrov AY, and Lakatta EG (2017) The Pressure of Aging. Med Clin North Am 101, 81–101 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Pletcher SD, and Stumpf MP (2002) Population genomics: ageing by association. Curr Biol 12, R328–330 [DOI] [PubMed] [Google Scholar]
- 3.Russell SJ, and Kahn CR (2007) Endocrine regulation of ageing. Nat Rev Mol Cell Biol 8, 681–691 [DOI] [PubMed] [Google Scholar]
- 4.Chang AR, Lazo M, Appel LJ, Gutierrez OM, and Grams ME (2014) High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III. Am J Clin Nutr 99, 320–327 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Ritter CS, and Slatopolsky E (2016) Phosphate Toxicity in CKD: The Killer among Us. Clin J Am Soc Nephrol 11, 1088–1100 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Takeda E, Yamamoto H, Nashiki K, Sato T, Arai H, and Taketani Y (2004) Inorganic phosphate homeostasis and the role of dietary phosphorus. J Cell Mol Med 8, 191–200 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Hu MC, Shiizaki K, Kuro-o M, and Moe OW (2013) Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev Physiol 75, 503–533 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Kuro-o M (2010) A potential link between phosphate and aging--lessons from Klotho-deficient mice. Mech Ageing Dev 131, 270–275 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.McGovern AP, de Lusignan S, van Vlymen J, Liyanage H, Tomson CR, Gallagher H, Rafiq M, and Jones S (2013) Serum phosphate as a risk factor for cardiovascular events in people with and without chronic kidney disease: a large community based cohort study. PLoS One 8, e74996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Ohnishi M, and Razzaque MS (2010) Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging. FASEB J 24, 3562–3571 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Osuka S, and Razzaque MS (2012) Can features of phosphate toxicity appear in normophosphatemia? J Bone Miner Metab 30, 10–18 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Hu MC, Shi M, Cho HJ, Adams-Huet B, Paek J, Hill K, Shelton J, Amaral AP, Faul C, Taniguchi M, Wolf M, Brand M, Takahashi M, Kuro OM, Hill JA, and Moe OW (2015) Klotho and phosphate are modulators of pathologic uremic cardiac remodeling. J Am Soc Nephrol 26, 1290–1302 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Feng Y, He D, Yao Z, and Klionsky DJ (2014) The machinery of macroautophagy. Cell Res 24, 24–41 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Hansen M, Rubinsztein DC, and Walker DW (2018) Autophagy as a promoter of longevity: insights from model organisms. Nat Rev Mol Cell Biol 19, 579–593 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Fernandez AF, Sebti S, Wei Y, Zou Z, Shi M, McMillan KL, He C, Ting T, Liu Y, Chiang WC, Marciano DK, Schiattarella GG, Bhagat G, Moe OW, Hu MC, and Levine B (2018) Disruption of the beclin 1-BCL2 autophagy regulatory complex promotes longevity in mice. Nature 558, 136–140 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Pyo JO, Yoo SM, Ahn HH, Nah J, Hong SH, Kam TI, Jung S, and Jung YK (2013) Overexpression of Atg5 in mice activates autophagy and extends lifespan. Nat Commun 4, 2300. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Rocchi A, Yamamoto S, Ting T, Fan Y, Sadleir K, Wang Y, Zhang W, Huang S, Levine B, Vassar R, and He C (2017) A Becn1 mutation mediates hyperactive autophagic sequestration of amyloid oligomers and improved cognition in Alzheimer’s disease. PLoS Genet 13, e1006962. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, and Nabeshima YI (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390, 45–51 [DOI] [PubMed] [Google Scholar]
- 19.Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Rosenblatt KP, Baum MG, Schiavi S, Hu MC, Moe OW, and Kuro-o M (2006) Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem 281, 6120–6123 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Kuro OM (2019) The Klotho proteins in health and disease. Nat Rev Nephrol 15, 27–44 [DOI] [PubMed] [Google Scholar]
- 21.Kuro-o M (2006) Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism. Curr Opin Nephrol Hypertens 15, 437–441 [DOI] [PubMed] [Google Scholar]
- 22.Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, Fujita T, Fukumoto S, and Yamashita T (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444, 770–77417086194 [Google Scholar]
- 23.Goetz R, Nakada Y, Hu MC, Kurosu H, Wang L, Nakatani T, Shi M, Eliseenkova AV, Razzaque MS, Moe OW, Kuro-o M, and Mohammadi M (2010) Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation. Proc Natl Acad Sci U S A 107, 407–412 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Hu MC, Shi M, Zhang J, Pastor J, Nakatani T, Lanske B, Razzaque MS, Rosenblatt KP, Baum MG, Kuro-o M, and Moe OW (2010) Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J 24, 3438–3450 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Consortium A (2000) Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26, 345–348 [DOI] [PubMed] [Google Scholar]
- 26.Hu MC, Shi M, Zhang J, Addo T, Cho HJ, Barker SL, Ravikumar P, Gillings N, Bian A, Sidhu SS, Kuro-o M, and Moe OW (2016) Renal Production, Uptake, and Handling of Circulating alphaKlotho. J Am Soc Nephrol 27, 79–90 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Chen CD, Podvin S, Gillespie E, Leeman SE, and Abraham CR (2007) Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17. Proc Natl Acad Sci U S A 104, 19796–19801 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Bloch L, Sineshchekova O, Reichenbach D, Reiss K, Saftig P, Kuro-o M, and Kaether C (2009) Klotho is a substrate for alpha-, beta- and gamma-secretase. FEBS Lett 583, 3221–3224 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Neyra JA, and Hu MC (2017) Potential application of klotho in human chronic kidney disease. Bone 100, 41–49 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Lu X, and Hu MC (2017) Klotho/FGF23 Axis in Chronic Kidney Disease and Cardiovascular Disease. Kidney Dis (Basel) 3, 15–23 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Chen G, Liu Y, Goetz R, Fu L, Jayaraman S, Hu MC, Moe OW, Liang G, Li X, and Mohammadi M (2018) alpha-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling. Nature 553, 461–466 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, McGuinness OP, Chikuda H, Yamaguchi M, Kawaguchi H, Shimomura I, Takayama Y, Herz J, Kahn CR, Rosenblatt KP, and Kuro-o M (2005) Suppression of aging in mice by the hormone Klotho. Science 309, 1829–1833 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Eren M, Boe AE, Murphy SB, Place AT, Nagpal V, Morales-Nebreda L, Urich D, Quaggin SE, Budinger GR, Mutlu GM, Miyata T, and Vaughan DE (2014) PAI-1-regulated extracellular proteolysis governs senescence and survival in Klotho mice. Proc Natl Acad Sci U S A 111, 7090–7095 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Watanabe R, Fujita N, Sato Y, Kobayashi T, Morita M, Oike T, Miyamoto K, Kuro OM, Michigami T, Fukumoto S, Tsuji T, Toyama Y, Nakamura M, Matsumoto M, and Miyamoto T (2017) Enpp1 is an anti-aging factor that regulates Klotho under phosphate overload conditions. Sci Rep 7, 7786. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Ohnishi M, Nakatani T, Lanske B, and Razzaque MS (2009) In vivo genetic evidence for suppressing vascular and soft-tissue calcification through the reduction of serum phosphate levels, even in the presence of high serum calcium and 1,25-dihydroxyvitamin d levels. Circ Cardiovasc Genet 2, 583–590 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Shi M, Flores B, Gillings N, Bian A, Cho HJ, Yan S, Liu Y, Levine B, Moe OW, and Hu MC (2016) alphaKlotho Mitigates Progression of AKI to CKD through Activation of Autophagy. J Am Soc Nephrol 27, 2331–2345 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y, Cattoretti G, and Levine B (2003) Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 112, 1809–1820 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.He C, Bassik MC, Moresi V, Sun K, Wei Y, Zou Z, An Z, Loh J, Fisher J, Sun Q, Korsmeyer S, Packer M, May HI, Hill JA, Virgin HW, Gilpin C, Xiao G, Bassel-Duby R, Scherer PE, and Levine B (2012) Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature 481, 511–515 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Hu MC, Shi M, Zhang J, Quinones H, Kuro-o M, and Moe OW (2010) Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective. Kidney Int 78, 1240–1251 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Hu MC, Shi M, Gillings N, Flores B, Takahashi M, Kuro OM, and Moe OW (2017) Recombinant alpha-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy. Kidney Int 91, 1104–1114 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Bian A, Shi M, Flores B, Gillings N, Li P, Yan SX, Levine B, Xing C, and Hu MC (2017) Downregulation of autophagy is associated with severe ischemia-reperfusion-induced acute kidney injury in overexpressing C-reactive protein mice. PLoS One 12, e0181848. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Vega-Rubin-de-Celis S, Zou Z, Fernandez AF, Ci B, Kim M, Xiao G, Xie Y, and Levine B (2018) Increased autophagy blocks HER2-mediated breast tumorigenesis. Proc Natl Acad Sci U S A 115, 4176–4181 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Peraro L, Zou Z, Makwana KM, Cummings AE, Ball HL, Yu H, Lin YS, Levine B, and Kritzer JA (2017) Diversity-Oriented Stapling Yields Intrinsically Cell-Penetrant Inducers of Autophagy. J Am Chem Soc 139, 7792–7802 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Barker SL, Pastor J, Carranza D, Quinones H, Griffith C, Goetz R, Mohammadi M, Ye J, Zhang J, Hu MC, Kuro-o M, Moe OW, and Sidhu SS (2015) The demonstration of alphaKlotho deficiency in human chronic kidney disease with a novel synthetic antibody. Nephrol Dial Transplant 30, 223–233 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Hu MC, Shi M, Zhang J, Quinones H, Griffith C, Kuro-o M, and Moe OW (2011) Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 22, 124–136 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Liu Y, Shoji-Kawata S, Sumpter RM Jr., Wei Y, Ginet V, Zhang L, Posner B, Tran KA, Green DR, Xavier RJ, Shaw SY, Clarke PG, Puyal J, and Levine B (2013) Autosis is a Na+,K+-ATPase-regulated form of cell death triggered by autophagy-inducing peptides, starvation, and hypoxia-ischemia. Proc Natl Acad Sci U S A 110, 20364–20371 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Shi M, Flores B, Li P, Gillings N, McMillan KL, Ye J, Huang LJ, Sidhu SS, Zhong YP, Grompe MT, Streeter PR, Moe OW, and Hu MC (2017) Effects of Erythropoietin Receptor Activity on Angiogenesis, Tubular Injury and Fibrosis in Acute Kidney Injury: A “U-Shaped” Relationship. Am J Physiol Renal Physiol, ajprenal 00306 02017 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutierrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P, Morales A, Scialla J, Fischer M, Soliman EZ, Chen J, Go AS, Rosas SE, Nessel L, Townsend RR, Feldman HI, St John Sutton M, Ojo A, Gadegbeku C, Di Marco GS, Reuter S, Kentrup D, Tiemann K, Brand M, Hill JA, Moe OW, Kuro OM, Kusek JW, Keane MG, and Wolf M (2011) FGF23 induces left ventricular hypertrophy. J Clin Invest 121, 4393–4408 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Shi M, McMillan KL, Wu J, Gillings N, Flores B, Moe OW, and Hu MC (2018) Cisplatin nephrotoxicity as a model of chronic kidney disease. Lab Invest 98, 1105–1121 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Biber J, Hernando N, Forster I, and Murer H (2009) Regulation of phosphate transport in proximal tubules. Pflugers Arch 458, 39–52 [DOI] [PubMed] [Google Scholar]
- 51.Yue Z, Jin S, Yang C, Levine AJ, and Heintz N (2003) Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A 100, 15077–15082 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Hu MC, Kuro-o M, and Moe OW (2014) alphaKlotho and vascular calcification: an evolving paradigm. Curr Opin Nephrol Hypertens 23, 331–339 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Takeshita K, Fujimori T, Kurotaki Y, Honjo H, Tsujikawa H, Yasui K, Lee JK, Kamiya K, Kitaichi K, Yamamoto K, Ito M, Kondo T, Iino S, Inden Y, Hirai M, Murohara T, Kodama I, and Nabeshima Y (2004) Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression. Circulation 109, 1776–1782 [DOI] [PubMed] [Google Scholar]
- 54.Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, Matsushita K, and Wen CP (2013) Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 382, 339–352 [DOI] [PubMed] [Google Scholar]
- 55.Crawford NM, and Steiner AZ (2015) Age-related infertility. Obstet Gynecol Clin North Am 42, 15–25 [DOI] [PubMed] [Google Scholar]
- 56.Schmitz G, and Muller G (1991) Structure and function of lamellar bodies, lipid-protein complexes involved in storage and secretion of cellular lipids. J Lipid Res 32, 1539–1570 [PubMed] [Google Scholar]
- 57.Hariri M, Millane G, Guimond MP, Guay G, Dennis JW, and Nabi IR (2000) Biogenesis of multilamellar bodies via autophagy. Mol Biol Cell 11, 255–268 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Garcia-Sanz P, Orgaz L, Fuentes JM, Vicario C, and Moratalla R (2018) Cholesterol and multilamellar bodies: Lysosomal dysfunction in GBA-Parkinson disease. Autophagy 14, 717–718 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Shoji-Kawata S, Sumpter R, Leveno M, Campbell GR, Zou Z, Kinch L, Wilkins AD, Sun Q, Pallauf K, MacDuff D, Huerta C, Virgin HW, Helms JB, Eerland R, Tooze SA, Xavier R, Lenschow DJ, Yamamoto A, King D, Lichtarge O, Grishin NV, Spector SA, Kaloyanova DV, and Levine B (2013) Identification of a candidate therapeutic autophagy-inducing peptide. Nature 494, 201–206 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Scialla JJ, and Wolf M (2014) Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease. Nat Rev Nephrol 10, 268–278 [DOI] [PubMed] [Google Scholar]
- 61.Morishita K, Shirai A, Kubota M, Katakura Y, Nabeshima Y, Takeshige K, and Kamiya T (2001) The progression of aging in klotho mutant mice can be modified by dietary phosphorus and zinc. J Nutr 131, 3182–3188 [DOI] [PubMed] [Google Scholar]
- 62.Schwarz C, Bohmig GA, Steininger R, Mayer G, and Oberbauer R (2001) Impaired phosphate handling of renal allografts is aggravated under rapamycin-based immunosuppression. Nephrol Dial Transplant 16, 378–382 [DOI] [PubMed] [Google Scholar]
- 63.Kawai M, Kinoshita S, Ozono K, and Michigami T (2016) Inorganic Phosphate Activates the AKT/mTORC1 Pathway and Shortens the Life Span of an alphaKlotho-Deficient Model. J Am Soc Nephrol 27, 2810–2824 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Kempe DS, Dermaku-Sopjani M, Frohlich H, Sopjani M, Umbach A, Puchchakayala G, Capasso A, Weiss F, Stubs M, Foller M, and Lang F (2010) Rapamycin-induced phosphaturia. Nephrol Dial Transplant 25, 2938–2944 [DOI] [PubMed] [Google Scholar]
- 65.Haller M, Amatschek S, Wilflingseder J, Kainz A, Bielesz B, Pavik I, Serra A, Mohebbi N, Biber J, Wagner CA, and Oberbauer R (2012) Sirolimus induced phosphaturia is not caused by inhibition of renal apical sodium phosphate cotransporters. PLoS One 7, e39229. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Hoorn EJ, and Severs D (2017) Autophagy and renal epithelial transport: eat to survive. Kidney Int 91, 1003–1005 [DOI] [PubMed] [Google Scholar]
- 67.Lanning NJ, VanOpstall C, Goodall ML, MacKeigan JP, and Looyenga BD (2018) LRRK2 deficiency impairs trans-Golgi to lysosome trafficking and endocytic cargo degradation in human renal proximal tubule epithelial cells. Am J Physiol Renal Physiol 315, F1465–F1477 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Khositseth S, Charngkaew K, Boonkrai C, Somparn P, Uawithya P, Chomanee N, Payne DM, Fenton RA, and Pisitkun T (2017) Hypercalcemia induces targeted autophagic degradation of aquaporin-2 at the onset of nephrogenic diabetes insipidus. Kidney Int 91, 1070–1087 [DOI] [PubMed] [Google Scholar]
- 69.Khositseth S, Uawithya P, Somparn P, Charngkaew K, Thippamom N, Hoffert JD, Saeed F, Michael Payne D, Chen SH, Fenton RA, and Pisitkun T (2015) Autophagic degradation of aquaporin-2 is an early event in hypokalemia-induced nephrogenic diabetes insipidus. Sci Rep 5, 18311. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Wei W, An XR, Jin SJ, Li XX, and Xu M (2018) Inhibition of insulin resistance by PGE1 via autophagy-dependent FGF21 pathway in diabetic nephropathy. Sci Rep 8, 9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Cherqui S, and Courtoy PJ (2017) The renal Fanconi syndrome in cystinosis: pathogenic insights and therapeutic perspectives. Nat Rev Nephrol 13, 115–131 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Grieco G, Janssens V, Gaide Chevronnay HP, N’Kuli F, Van Der Smissen P, Wang T, Shan J, Vainio S, Bilanges B, Jouret F, Vanhaesebroeck B, Pierreux CE, and Courtoy PJ (2018) Vps34/PI3KC3 deletion in kidney proximal tubules impairs apical trafficking and blocks autophagic flux, causing a Fanconi-like syndrome and renal insufficiency. Sci Rep 8, 14133. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Wagner CA, Rubio-Aliaga I, and Hernando N (2019) Renal phosphate handling and inherited disorders of phosphate reabsorption: an update. Pediatr Nephrol 34, 549–559 [DOI] [PubMed] [Google Scholar]
- 74.Biber J, Hernando N, and Forster I (2013) Phosphate transporters and their function. Annu Rev Physiol 75, 535–550 [DOI] [PubMed] [Google Scholar]
- 75.Hu MC, Shi M, and Moe OW (2019) Role of alphaKlotho and FGF23 in regulation of type II Na-dependent phosphate co-transporters. Pflugers Arch 471, 99–108 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Bian A, Xing C, and Hu MC (2014) Alpha Klotho and phosphate homeostasis. J Endocrinol Invest 37, 1121–1126 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Scanni R, vonRotz M, Jehle S, Hulter HN, and Krapf R (2014) The human response to acute enteral and parenteral phosphate loads. J Am Soc Nephrol 25, 2730–2739 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Shiraki-Iida T, Iida A, Nabeshima Y, Anazawa H, Nishikawa S, Noda M, Kuro-o M, and Nabeshima Y (2000) Improvement of multiple pathophysiological phenotypes of klotho (kl/kl) mice by adenovirus-mediated expression of the klotho gene. J Gene Med 2, 233–242 [DOI] [PubMed] [Google Scholar]
- 79.Chen TH, Kuro OM, Chen CH, Sue YM, Chen YC, Wu HH, and Cheng CY (2013) The secreted Klotho protein restores phosphate retention and suppresses accelerated aging in Klotho mutant mice. Eur J Pharmacol 698, 67–73 [DOI] [PubMed] [Google Scholar]
- 80.Dai XY, Zhao MM, Cai Y, Guan QC, Zhao Y, Guan Y, Kong W, Zhu WG, Xu MJ, and Wang X (2013) Phosphate-induced autophagy counteracts vascular calcification by reducing matrix vesicle release. Kidney Int 83, 1042–1051 [DOI] [PubMed] [Google Scholar]
- 81.Zhang YY, Yang M, Bao JF, Gu LJ, Yu HL, and Yuan WJ (2018) Phosphate stimulates myotube atrophy through autophagy activation: evidence of hyperphosphatemia contributing to skeletal muscle wasting in chronic kidney disease. BMC Nephrol 19, 45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Shanahan CM (2013) Autophagy and matrix vesicles: new partners in vascular calcification. Kidney Int 83, 984–986 [DOI] [PubMed] [Google Scholar]
- 83.Hsu YJ, Hsu SC, Huang SM, Lee HS, Lin SH, Tsai CS, Shih CC, and Lin CY (2015) Hyperphosphatemia induces protective autophagy in endothelial cells through the inhibition of Akt/mTOR signaling. J Vasc Surg 62, 210–221 e212 [DOI] [PubMed] [Google Scholar]
- 84.Hu MC, Fan L, Crowder LA, Karim-Jimenez Z, Murer H, and Moe OW (2001) Dopamine acutely stimulates Na+/H+ exchanger (NHE3) endocytosis via clathrin-coated vesicles: dependence on protein kinase A-mediated NHE3 phosphorylation. J Biol Chem 276, 26906–26915 [DOI] [PubMed] [Google Scholar]
- 85.Pous C, and Codogno P (2011) Lysosome positioning coordinates mTORC1 activity and autophagy. Nat Cell Biol 13, 342–344 [DOI] [PubMed] [Google Scholar]
- 86.Dunn WA Jr. (1994) Autophagy and related mechanisms of lysosome-mediated protein degradation. Trends Cell Biol 4, 139–143 [DOI] [PubMed] [Google Scholar]
- 87.Zhang X, Yu L, and Xu H (2016) Lysosome calcium in ROS regulation of autophagy. Autophagy 12, 1954–1955 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.